Dunhill Financial’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.35K Sell
8
-1
-11% -$271 ﹤0.01% 761
2025
Q4
$2.18K Buy
9
+1
+13% +$266 ﹤0.01% 725
2025
Q3
$2.19K Buy
8
+1
+14% +$268 ﹤0.01% 686
2025
Q2
$2.01K Sell
7
-1
-13% -$244 ﹤0.01% 682
2025
Q1
$1.8K Sell
8
-5
-38% -$1.21K ﹤0.01% 755
2024
Q4
$2.88K Buy
13
+5
+63% +$1.15K ﹤0.01% 654
2024
Q3
$1.74K Hold
8
﹤0.01% 739
2024
Q2
$1.55K Buy
8
+1
+14% +$203 ﹤0.01% 620
2024
Q1
$1.63K Buy
7
+1
+17% +$220 ﹤0.01% 542
2023
Q4
$1.42K Buy
+6
New +$1.26K ﹤0.01% 523

Other funds holding LH

Dunhill Financial's LH Position: Q1 2026 in Review

Dunhill Financial reduced its Labcorp (LH) stake by 11% in Q1 2026, selling an estimated $271 and leaving 8 shares worth $2.35K. The position accounts for ﹤0.01% of the portfolio, ranked #761.

Dunhill Financial first reported a position in LH in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.88K in Q4 2024. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Dunhill Financial held 8 shares of Labcorp worth $2.35K as of Q1 2026.
  • Dunhill Financial sold 1 Labcorp share in Q1 2026, an estimated $271.
  • Labcorp made up ﹤0.01% of Dunhill Financial's portfolio in Q1 2026, its #761 holding.
  • Dunhill Financial first reported a position in Labcorp in Q4 2023 and has held it in 10 quarters since.
  • Dunhill Financial's Labcorp position peaked at $2.88K in Q4 2024.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Dunhill Financial's 13F filing for Q1 2026, filed 6 May 2026.